| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 87 |
| 1 | ASPIRIN 325 MG | 84 |
| 2 | ASPIRIN 81 MG | 84 |
| 3 | PREDNISONE | 81 |
| 4 | ACETAMINOPHEN | 71 |
| 5 | OMEPRAZOLE MAGNESIUM | 68 |
| 6 | APIXABAN | 59 |
| 7 | FUROSEMIDE | 59 |
| 8 | METHOTREXATE SODIUM | 58 |
| 9 | CISPLATIN | 57 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETHANOLAMINE OLEATE | 1 | 0.0556 |
| 1 | ANGIOTENSIN II | 5 | 0.0167 |
| 2 | AVANAFIL | 1 | 0.0143 |
| 3 | ETHIODIZED OIL | 18 | 0.0139 |
| 4 | OLODATEROL RESPIMAT INHALATION SPRAY | 4 | 0.0108 |
| 5 | CARBON DIOXIDE | 1 | 0.0087 |
| 6 | DICLOFENAC SODIUM/MISOPROSTOL | 3 | 0.0068 |
| 7 | SORBITOL | 4 | 0.0066 |
| 8 | NITROFURANTOIN (MACROCRYSTALS) | 4 | 0.0065 |
| 9 | FLOXURIDINE | 1 | 0.0058 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 227 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 163 |
| 2 | Kinase Inhibitor [EPC] | 116 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 113 |
| 4 | Factor Xa Inhibitor [EPC] | 106 |
| 5 | Proton Pump Inhibitor [EPC] | 99 |
| 6 | Platinum-based Drug [EPC] | 93 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 91 |
| 8 | Loop Diuretic [EPC] | 73 |
| 9 | Benzodiazepine [EPC] | 69 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasoconstrictor [EPC] | 5 | 0.0167 |
| 1 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 2 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 23 | 0.0018 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 10 | 0.0017 |
| 5 | CD22-directed Immunoconjugate [EPC] | 5 | 0.0017 |
| 6 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 7 | Hematopoietic Stem Cell Mobilizer [EPC] | 2 | 0.0013 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 11 | 0.0013 |
| 9 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |